Literature DB >> 11197691

Characterization of new polymorphisms in the 5' UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level.

R Bergholdt1, Z M Larsen, N A Andersen, J Johannesen, O P Kristiansen, T Mandrup-Poulsen, J Nerup, F Pociot.   

Abstract

The human interleukin-1 type I receptor (IL-1RI) is the signal transducing receptor for IL-1, a principal proinflammatory cytokine, which is cytotoxic to pancreatic islet beta cells. The IL-1RI gene, IL1R1, maps to chromosome 2q12. We have previously examined part of the IL1R1 promoter region and in the present study we further characterized the promoter region demarcating exon 1B and 1C by sequencing and mutation scanning. New sequence was obtained 1762 bp upstream and 1609 bp downstream the known region. Within this sequence, we identified four frequent single nucleotide polymorphisms (SNPs). PCR-based RFLP assays were established and three of the polymorphisms were typed in a Danish Type 1 (insulin-dependent) diabetes mellitus (T1DM) family collection comprising 103 simplex and 150 sib-pair affected families. Linkage was evaluated by the sib-TDT (transmission disequilibrium test). One of the polymorphisms, defined by a Hinfl RFLP assay, demonstrated linkage to T1DM, P(sTDT) = 0.026. Random transmission was observed to unaffected offspring from heterozygous parents, P = 0.87. No evidence for positive linkage was seen for the other tested polymorphisms, P = 0.14 and P = 0.21, respectively. To evaluate the possible functional significance of the Hinfl polymorphism, we measured circulating IL-1RI plasma level in 30 T1DM patients and in 30 control subjects--10 with each genotype in both groups. Significant differences in plasma levels in relation to genotype--independent of disease status--were found (P = 0.04). In both diabetic and non-diabetic subjects, the wt/wt genotype correlated with the highest IL-1RI plasma level, whereas the plasma levels were lowest for the mt/mt genotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11197691     DOI: 10.1038/sj.gene.6363719

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  6 in total

1.  Genetics of the bone response to bisphosphonate treatments.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

2.  Evaluation and integration of 49 genome-wide experiments and the prediction of previously unknown obesity-related genes.

Authors:  Sangeeta B English; Atul J Butte
Journal:  Bioinformatics       Date:  2007-10-05       Impact factor: 6.937

3.  FokI polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population.

Authors:  Tatijana Zemunik; Veselin Skrabic; Vesna Boraska; Dijaneta Diklic; Ivana Marinovic Terzic; Vesna Capkun; Marijana Peruzovic; Janos Terzic
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

4.  A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer.

Authors:  Steve Hartland; Julia L Newton; S Michael Griffin; Pete T Donaldson
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

5.  IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort.

Authors:  X Wu; V Kondragunta; K S Kornman; H Y Wang; G W Duff; J B Renner; J M Jordan
Journal:  Osteoarthritis Cartilage       Date:  2013-04-18       Impact factor: 6.576

6.  GWAS for Interleukin-1β levels in gingival crevicular fluid identifies IL37 variants in periodontal inflammation.

Authors:  Steven Offenbacher; Yizu Jiao; Steven J Kim; Julie Marchesan; Kevin L Moss; Li Jing; Kimon Divaris; Sompop Bencharit; Cary S Agler; Thiago Morelli; Shaoping Zhang; Lu Sun; William T Seaman; Dale Cowley; Silvana P Barros; James D Beck; Matthias Munz; Arne S Schaefer; Kari E North
Journal:  Nat Commun       Date:  2018-09-11       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.